Tobam Has $5.86 Million Stock Position in The Clorox Company $CLX

Tobam lifted its holdings in The Clorox Company (NYSE:CLX) by 16.9% during the second quarter, HoldingsChannel.com reports. The firm owned 48,784 shares of the company’s stock after purchasing an additional 7,048 shares during the period. Clorox accounts for 2.3% of Tobam’s portfolio, making the stock its 11th biggest position. Tobam’s holdings in Clorox were worth $5,857,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. American National Bank & Trust lifted its position in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after buying an additional 89 shares in the last quarter. NewSquare Capital LLC grew its stake in Clorox by 567.6% in the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares in the last quarter. Hantz Financial Services Inc. acquired a new position in Clorox during the second quarter worth $31,000. Ransom Advisory Ltd acquired a new stake in Clorox in the first quarter valued at $35,000. Finally, GW&K Investment Management LLC increased its position in Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after buying an additional 208 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CLX. Bank of America reduced their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 28th. UBS Group set a $119.00 target price on Clorox and gave the stock a “neutral” rating in a report on Tuesday, November 4th. Finally, Citigroup decreased their price target on shares of Clorox from $130.00 to $120.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $125.69.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $104.99 on Wednesday. The stock has a market cap of $12.81 billion, a PE ratio of 16.10, a P/E/G ratio of 0.92 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The business’s 50-day moving average price is $118.92 and its two-hundred day moving average price is $124.26. The Clorox Company has a 12-month low of $104.08 and a 12-month high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox’s revenue for the quarter was down 18.9% on a year-over-year basis. During the same quarter last year, the business posted $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd were given a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.7%. The ex-dividend date was Wednesday, October 22nd. Clorox’s dividend payout ratio is 77.86%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.